Targeting the IGF-1R signaling and mechanisms for epigenetic gene silencing in human multiple myeloma

被引:9
|
作者
Jernberg-Wiklund, Helena [1 ]
Nilsson, Kenneth [1 ]
机构
[1] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, SE-75185 Uppsala, Sweden
关键词
Epigenetics; IGF-1; multiple myeloma; GROWTH-FACTOR-I; RECEPTOR TYROSINE KINASE; TUMOR-SUPPRESSOR GENES; MONOCLONAL GAMMOPATHY; MOUSE MODEL; MOLECULAR CLASSIFICATION; HEMATOLOGIC MALIGNANCIES; EXPRESSION SIGNATURE; INHIBITS GROWTH; CYCLOLIGNAN PPP;
D O I
10.3109/03009734.2012.659293
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Multiple myeloma (MM) is a B cell malignancy characterized by the expansion of clonal plasmablast/plasma cells within the bone-marrow. It is well established that the bone-marrow microenvironment has a pivotal role in providing critical cytokines and cell-cell interactions to support the growth and survival of the MM tumor clone. The pathogenesis of MM is, however, only fragmentarily understood. Detailed genomic analysis reveals a heterogeneous and complex pattern of structural and numerical chromosomal aberrations. In this review we will discuss some of the recent results on the functional role and potential clinical use of the IGF-1R, one of the major mediators of growth and survival for MM. We will also describe some of our results on epigenetic gene silencing in MM, as it may indeed constitute a novel basis for the understanding of tumor initiation and maintenance in MM and thus may change the current view on treatment strategies for MM.
引用
收藏
页码:166 / 177
页数:12
相关论文
共 50 条
  • [1] Mechanisms of acquired resistance to an IGF-1R inhibitor in multiple models
    Huang, Fei
    Hurlburt, Warren
    Greer, Ann
    Reeves, Karen A.
    Hillerman, Stephen
    Chang, Han
    Emanuel, Stuart
    Finckenstein, Friedrich
    Gottardis, Marco M.
    Carboni, Joan M.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [2] IGF-1R is overexpressed in poor-prognostic subtypes of multiple myeloma
    Chng, WJ
    Gualberto, A
    Fonseca, R
    [J]. LEUKEMIA, 2006, 20 (01) : 174 - 176
  • [3] IGF-1R is overexpressed in poor-prognostic subtypes of multiple myeloma
    W J Chng
    A Gualberto
    R Fonseca
    [J]. Leukemia, 2006, 20 : 174 - 176
  • [4] Blockade of IGF/IGF-1R signaling axis with soluble IGF-1R mutants suppresses the cell proliferation and tumor growth of human osteosarcoma
    Cao, Daigui
    Lei, Yan
    Ye, Zhenyu
    Zhao, Ling
    Wang, Hao
    Zhang, Jing
    He, Fang
    Huang, Linjuan
    Shi, Deyao
    Liu, Qing
    Ni, Na
    Pakvasa, Mikhail
    Wagstaff, William
    Zhao, Xia
    Fu, Kai
    Tucker, Andrew B.
    Chen, Connie
    Reid, Russell R.
    Haydon, Rex C.
    Luu, Hue H.
    He, Tong-Chuan
    Liao, Zhan
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (10): : 3248 - +
  • [5] Significance of IGF-1R and Its signaling pathways in human sarcoma
    Yang, Jia Lin
    DasGupta, Romi
    Hopkins, Alyse
    Luk, Frederick
    Goldstein, David
    Crowe, Philip
    [J]. CANCER RESEARCH, 2011, 71
  • [6] Tumorigenicity of IGF-1R and IR: Rationale for co-targeting IGF-1R and IR in cancer
    Lerner, Lorena
    Liu, Qing
    Tao, Nianjun
    Yang, John
    Brown, Eric
    Koujak, Susan
    Krieger, Brian
    Huang, Lu
    Rosenfeld-Franklin, Maryland
    Miglarese, Mark
    Pachter, Jonathan
    Robinson, Murray O.
    Chiu, M. Isabel
    Epstein, David
    Buck, Elizabeth
    [J]. CANCER RESEARCH, 2011, 71
  • [7] Regulation of the IGF-1R signaling by angiotensin signaling pathway
    Boo, Hye-Jin
    Jang, Hyun-Ji
    Jung, Yujin
    Min, Hye-Young
    Lee, Ho-Young
    [J]. CANCER RESEARCH, 2015, 75
  • [8] Targeting the IGF-1R: the tale of the tortoise and the hare
    Crudden, Caitrin
    Girnita, Ada
    Girnita, Leonard
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2015, 6
  • [9] Disorders of IGFs and IGF-1R signaling pathways
    Forbes, Briony E.
    Blyth, Andrew J.
    Wit, Jan M.
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2020, 518
  • [10] XGFR, an Fc-engineered dual signaling inhibitor targeting IGF-1R and EGFR
    Wartha, Katharina
    Croasdale, Rebecca
    Schanzer, Juergen
    Brinkmann, Ulrich
    Hofmann, Marco H.
    Ries, Carola
    Rieder, Natascha
    Hoelzlwimmer, Gabriele
    Freytag, Olivier
    Herter, Sylvia
    Gerdes, Christian
    Kuenkele, Klaus-Peter
    Klein, Christian
    [J]. CANCER RESEARCH, 2011, 71